Signos vs Biolinq

Signos is an AI-powered continuous glucose monitoring platform for weight management, cleared by the FDA as the first OTC CGM system for that use.

Biolinq builds a coin-sized intradermal biosensor patch that continuously monitors glucose just beneath the skin's surface for people managing metabolic health.